- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
August 12th, 2010
Dexter Johnson: "While the argument that just because some nanoparticles are in the paint coating of a Mercedes Benz doesn't mean you can attach the entire value of that car to nanotech is appealing, it doesn't quite hold up when a few pennies of a nanoparticle are used in a drug formulation.
I have tried to explain this seemingly simple economic concept before, but it apparently bears repeating. If the drug cannot be formulated so it possesses a new and improved delivery system and efficacy without the nanoparticle, then the new drug does not come into being. Therefore there is no value without the nanoparticle but with it there is. Sine qua non. Maybe a little Latin will clear that up."
While I am growing somewhat weary with this polemic, I suppose I will feel compelled to raise it at least every time that Nanowerk characterizes attempts to actually estimate the impact of nanotechnology on various markets as something less than honest.
|Related News Press|
News and information
Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015
Engineering the world’s smallest nanocrystal July 2nd, 2015
Newly-Developed Biosensor in Iran Detects Cocaine Addiction June 23rd, 2015